Brainsway (BWAY) Change in Account Payables (2018 - 2026)
Brainsway (BWAY) posted quarterly Change in Account Payables of $526000.0 for Q1 2026, up 171.08% year-on-year from $194037.9 in Q1 2025, and up 255.62% on a QoQ basis from -$338000.0 in Q4 2025.
Brainsway (BWAY) Change in Account Payables (2018 - 2026) Analysis & Trends
Brainsway (BWAY) has reported Change in Account Payables for 9 consecutive years, with $526000.0 the latest figure, recorded in Q1 2026.
- Quarterly Change in Account Payables rose 171.08% year-over-year to $526000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $789000.0 (down 35.8% YoY) and the FY2025 annual result came in at $768000.0, down 63.76% from the prior year.
- Change in Account Payables rose to $526000.0 in Q1 2026 per BWAY's latest filing, from -$338000.0 in the prior quarter.
- Over the last five years, Change in Account Payables for BWAY reached as high as $1.6 million in Q4 2024 and fell as low as -$950000.0 in Q2 2025.
- A 5-year average of $108294.1 and a median of -$58000.0 in 2023 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2024 — Change in Account Payables jumped 1686.96% — and 2025, when it tumbled 593.33%.
- Year by year, Change in Account Payables stood at -$169000.0 in 2022, then surged by 284.62% to $312000.0 in 2023, then jumped by 414.42% to $1.6 million in 2024, then tumbled by 121.06% to -$338000.0 in 2025, then surged by 255.62% to $526000.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $526000.0, -$338000.0, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn | - |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | 221.00 Mn |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn | - |
| 10 | Brainsway | 590.98 Mn | 531.21 Mn | 11.68 Mn | 526,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 526,000.00 |
| Mar 31, 2026 | 526,000.00 |
| Dec 31, 2025 | -338,000.00 |
| Dec 31, 2025 | -338,000.00 |
| Sep 30, 2025 | 1.55 Mn |
| Sep 30, 2025 | 1.55 Mn |
| Jun 30, 2025 | -950,000.00 |
| Jun 30, 2025 | -950,000.00 |
| Mar 31, 2025 | -740,000.00 |
| Mar 31, 2025 | -740,000.00 |
| Dec 31, 2024 | 1.61 Mn |
| Dec 31, 2024 | 1.61 Mn |
| Sep 30, 2024 | -366,000.00 |
| Sep 30, 2024 | -366,000.00 |
| Jun 30, 2024 | 730,000.00 |
| Jun 30, 2024 | 730,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Dec 31, 2023 | 312,000.00 |
| Dec 31, 2023 | 312,000.00 |